Accessing the inaccessible: research bridging academia and industry – an interview with Tatiana Rogova
Member Exclusive Interview
Expert interviews, Drug discovery approaches, Drug regulation and industry, Preclinical studies and Phase I, Technologies and methodologies, Neurological & Psychiatric , Respiratory , Cardiovascular , Digestive , Infectious , Cancer , Early Career Room
Advancing the discovery of CNS active drugs: an interview with Li Yu and Holger Fischer
Inhibitor analysis for Alzheimer’s points towards a polypharmacology approach: abstract highlights from PharmSci360 day 3
Latest news, Computational chemistry and informatics, Novel lead compounds, Drug repurposing, Therapeutic targets, Neurological & Psychiatric , Infectious , Cancer
How is 3D tissue modeling opening new doors for ALS drug testing?